# FDA Inspection 858060 - Columbus CCOP IRB - December 18, 2013

Source: https://www.keypedia.com/records/fda_inspections/columbus-ccop-irb/ecd60efa-1f89-4e81-a7a8-7bca0f3306fb
Source feed: FDA_Inspections

> FDA Inspection 858060 for Columbus CCOP IRB on December 18, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 858060
- Company Name: Columbus CCOP IRB
- Inspection Date: 2013-12-18
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1129382 - 2020-09-10](https://www.keypedia.com/records/fda_inspections/columbus-ccop-irb/07a4b671-ea99-4d4f-bd21-b807a7cb137c)
- [FDA Inspection 1129382 - 2020-09-10](https://www.keypedia.com/records/fda_inspections/columbus-ccop-irb/ad1f8fe4-e8e8-45ee-9d07-cd873966f85a)
- [FDA Inspection 625767 - 2009-11-10](https://www.keypedia.com/records/fda_inspections/columbus-ccop-irb/cf0c8bf2-ec6c-482a-87b1-166cfef9d331)

Company: https://www.keypedia.com/companies/columbus-ccop-irb/94ba43a0-7e1e-4b3b-9227-66e66f379745

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c